eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
5/2021
vol. 53
 
Share:
Share:
more
 
 
abstract:
Review paper

Use of direct oral anticoagulants in ICU patients. Part II – Clinical evidence

Abdul Wahab
1
,
Rupali Patnaik
2
,
Mohan Gurjar
2

1.
University of Iowa Hospitals and Clinics, Iowa City, United States
2.
Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India
Anaesthesiol Intensive Ther 2021; 53, 5: 440–449
Online publish date: 2021/11/24
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
During the last decade, utilization of direct oral anticoagulants (DOACs) has increased due to their pharmacokinetic profile and the fact that they are non-inferior to warfarin in the prevention of stroke in patients with atrial fibrillation, as well as for the treatment of venous thromboembolism. However, there are few studies about their use in critically ill patients. This article aims to review available evidence on the use of DOACs in the indicated conditions and anticoagulant management of medical or surgical patients receiving DOAC before intensive care unit (ICU) admission. The rapidly changing pathophysiology and heterogeneous nature of critically ill patients combined with limited evidence often leads to a high degree of individualization of DOAC regimens in ICU patients. This article is the second part of the narrative review series on the use of DOACs in ICU patients, focusing on current “Clinical evidence”. “Applied pharma­cology” has been described in the first part.
keywords:

surgery, stroke, venous thromboembolism, bleeding, intensive care unit, atrial fibrillation, critically ill, oral anticoagulant

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.